BRCA1 and BRCA2 (heretofore BRCA) germline pathogenic variant (PVs) carriers are at a significantly higher risk for breast cancer (BC), with estimated cumulative lifetime risk of 55% to 65% and 45% to 47%, respectively [1,2]. Here, BRCA2 is linked to breast carcinoma.